147 related articles for article (PubMed ID: 36624516)
21. Extracellular vesicle-circEHD2 promotes the progression of renal cell carcinoma by activating cancer-associated fibroblasts.
He T; Zhang Q; Xu P; Tao W; Lin F; Liu R; Li M; Duan X; Cai C; Gu D; Zeng G; Liu Y
Mol Cancer; 2023 Jul; 22(1):117. PubMed ID: 37481520
[TBL] [Abstract][Full Text] [Related]
22. IL1R1
Koncina E; Nurmik M; Pozdeev VI; Gilson C; Tsenkova M; Begaj R; Stang S; Gaigneaux A; Weindorfer C; Rodriguez F; Schmoetten M; Klein E; Karta J; Atanasova VS; Grzyb K; Ullmann P; Halder R; Hengstschläger M; Graas J; Augendre V; Karapetyan YE; Kerger L; Zuegel N; Skupin A; Haan S; Meiser J; Dolznig H; Letellier E
Nat Commun; 2023 Jul; 14(1):4251. PubMed ID: 37460545
[TBL] [Abstract][Full Text] [Related]
23. Tumor-derived Cav-1 promotes pre-metastatic niche formation and lung metastasis in breast cancer.
Wang Y; Li Y; Zhong J; Li M; Zhou Y; Lin Q; Zong S; Luo W; Wang J; Wang K; Wang J; Xiong L
Theranostics; 2023; 13(5):1684-1697. PubMed ID: 37056561
[No Abstract] [Full Text] [Related]
24. Loss of cancer-associated fibroblast-derived exosomal DACT3-AS1 promotes malignant transformation and ferroptosis-mediated oxaliplatin resistance in gastric cancer.
Qu X; Liu B; Wang L; Liu L; Zhao W; Liu C; Ding J; Zhao S; Xu B; Yu H; Zhang X; Chai J
Drug Resist Updat; 2023 May; 68():100936. PubMed ID: 36764075
[TBL] [Abstract][Full Text] [Related]
25. Retraction notice to "MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer" [Gynecologic Oncology, Volume 110, Issue 1, July 2008, Pages 13-21].
Taylor DD; Gercel-Taylor C
Gynecol Oncol; 2023 Aug; 175():192. PubMed ID: 37479418
[No Abstract] [Full Text] [Related]
26. Label-Free Quantification Mass Spectrometry Identifies Protein Markers of Chemotherapy Response in High-Grade Serous Ovarian Cancer.
Arentz G; Mittal P; Klingler-Hoffmann M; Condina MR; Ricciardelli C; Lokman NA; Kaur G; Oehler MK; Hoffmann P
Cancers (Basel); 2023 Apr; 15(7):. PubMed ID: 37046833
[TBL] [Abstract][Full Text] [Related]
27. Serum Exosomes From Epithelial Ovarian Cancer Patients Contain LRP1, Which Promotes the Migration of Epithelial Ovarian Cancer Cell.
Zhou W; Ma J; Zhao H; Wang Q; Guo X; Chen L; Cao Z; Xu J; Zhang B; Zhou X
Mol Cell Proteomics; 2023 Apr; 22(4):100520. PubMed ID: 36842607
[TBL] [Abstract][Full Text] [Related]
28. Metastasis-associated fibroblasts in peritoneal surface malignancies.
Ramos C; Gerakopoulos V; Oehler R
Br J Cancer; 2024 May; ():. PubMed ID: 38783165
[TBL] [Abstract][Full Text] [Related]
29. MicroRNA Expression Profiles in Human Samples and Cell Lines Revealed Nine miRNAs Associated with Cisplatin Resistance in High-Grade Serous Ovarian Cancer.
Flores-Colón M; Rivera-Serrano M; Reyes-Burgos VG; Rolón JG; Pérez-Santiago J; Marcos-Martínez MJ; Valiyeva F; Vivas-Mejía PE
Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612604
[TBL] [Abstract][Full Text] [Related]
30. The rising roles of exosomes in the tumor microenvironment reprogramming and cancer immunotherapy.
Wu Y; Han W; Dong H; Liu X; Su X
MedComm (2020); 2024 Apr; 5(4):e541. PubMed ID: 38585234
[TBL] [Abstract][Full Text] [Related]
31. Drug resistance in ovarian cancer: from mechanism to clinical trial.
Wang L; Wang X; Zhu X; Zhong L; Jiang Q; Wang Y; Tang Q; Li Q; Zhang C; Wang H; Zou D
Mol Cancer; 2024 Mar; 23(1):66. PubMed ID: 38539161
[TBL] [Abstract][Full Text] [Related]
32. An exosome-derived lncRNA signature identified by machine learning associated with prognosis and biomarkers for immunotherapy in ovarian cancer.
Cui Y; Zhang W; Lu W; Feng Y; Wu X; Zhuo Z; Zhang D; Zhang Y
Front Immunol; 2024; 15():1228235. PubMed ID: 38404588
[TBL] [Abstract][Full Text] [Related]
33. Fibroblasts: invigorated targets in pre-metastatic niche formation.
Han H; Qian C; Song M; Zhong C; Zhao Y; Lu Y
Int J Biol Sci; 2024; 20(3):1110-1124. PubMed ID: 38322116
[TBL] [Abstract][Full Text] [Related]
34. Extracellular vesicles remodel tumor environment for cancer immunotherapy.
Yue M; Hu S; Sun H; Tuo B; Jia B; Chen C; Wang W; Liu J; Liu Y; Sun Z; Hu J
Mol Cancer; 2023 Dec; 22(1):203. PubMed ID: 38087360
[TBL] [Abstract][Full Text] [Related]
35. Hypoxia-induced exosomes facilitate lung pre-metastatic niche formation in hepatocellular carcinoma through the miR-4508-RFX1-IL17A-p38 MAPK-NF-κB pathway.
Jia W; Liang S; Lin W; Li S; Yuan J; Jin M; Nie S; Zhang Y; Zhai X; Zhou L; Ling C; Cheng B; Ling C
Int J Biol Sci; 2023; 19(15):4744-4762. PubMed ID: 37781522
[No Abstract] [Full Text] [Related]
36. Exosomal miR-222-3p contributes to castration-resistant prostate cancer by activating mTOR signaling.
Wang W; Kong P; Feng K; Liu C; Gong X; Sun T; Duan X; Sang Y; Jiang Y; Li X; Zhang L; Tao Z; Liu W
Cancer Sci; 2023 Nov; 114(11):4252-4269. PubMed ID: 37671589
[TBL] [Abstract][Full Text] [Related]
37. The Role and Applications of Exosomes in Gynecological Cancer: A Review.
Wang KH; Ding DC
Cell Transplant; 2023; 32():9636897231195240. PubMed ID: 37632354
[TBL] [Abstract][Full Text] [Related]
38. miRNAs Delivery for Cancer-associated Fibroblasts' Activation and Drug Resistance in Cancer Microenvironment.
Anajafi S; Paryan M; Khoshnazar A; Soleimani M; Mohammadi-Yeganeh S
Endocr Metab Immune Disord Drug Targets; 2024; 24(3):333-347. PubMed ID: 37612874
[TBL] [Abstract][Full Text] [Related]
39. "DEPHENCE" system-a novel regimen of therapy that is urgently needed in the high-grade serous ovarian cancer-a focus on anti-cancer stem cell and anti-tumor microenvironment targeted therapies.
Wilczyński JR; Wilczyński M; Paradowska E
Front Oncol; 2023; 13():1201497. PubMed ID: 37448521
[TBL] [Abstract][Full Text] [Related]
40. Exosomes: Diagnostic and Therapeutic Implications in Cancer.
Jo H; Shim K; Jeoung D
Pharmaceutics; 2023 May; 15(5):. PubMed ID: 37242707
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
